These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1350 related articles for article (PubMed ID: 17957277)

  • 1. Molecular pathology and pharmacogenomics in Alzheimer's disease: polygenic-related effects of multifactorial treatments on cognition, anxiety and depression.
    Cacabelos R
    Methods Find Exp Clin Pharmacol; 2007 Jul; 29 Suppl A():1-91. PubMed ID: 17957277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenomics in Alzheimer's disease.
    Cacabelos R
    Methods Mol Biol; 2008; 448():213-357. PubMed ID: 18370236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of pharmacogenetic factors on Alzheimer's disease therapeutics.
    Cacabelos R
    Neurodegener Dis; 2008; 5(3-4):176-8. PubMed ID: 18322383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenomics and therapeutic strategies for dementia.
    Cacabelos R
    Expert Rev Mol Diagn; 2009 Sep; 9(6):567-611. PubMed ID: 19732004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenomics and therapeutic prospects in dementia.
    Cacabelos R
    Eur Arch Psychiatry Clin Neurosci; 2008 Mar; 258 Suppl 1():28-47. PubMed ID: 18344047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomics and phenotypic profiles in dementia: implications for pharmacological treatment.
    Cacabelos R; Fernández-Novoa L; Corzo L; Pichel V; Lombardi V; Kubota Y
    Methods Find Exp Clin Pharmacol; 2004; 26(6):421-44. PubMed ID: 15349138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenomics and therapeutic prospects in Alzheimer's disease.
    Cacabelos R
    Expert Opin Pharmacother; 2005 Oct; 6(12):1967-87. PubMed ID: 16197352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenetic basis for therapeutic optimization in Alzheimer's disease.
    Cacabelos R
    Mol Diagn Ther; 2007; 11(6):385-405. PubMed ID: 18078356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The application of functional genomics to Alzheimer's disease.
    Cacabelos R
    Pharmacogenomics; 2003 Sep; 4(5):597-621. PubMed ID: 12943467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenomics of Alzheimer's disease: novel therapeutic strategies for drug development.
    Cacabelos R; Cacabelos P; Torrellas C; Tellado I; Carril JC
    Methods Mol Biol; 2014; 1175():323-556. PubMed ID: 25150875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular genetics of Alzheimer's disease and aging.
    Cacabelos R; Fernandez-Novoa L; Lombardi V; Kubota Y; Takeda M
    Methods Find Exp Clin Pharmacol; 2005 Jul; 27 Suppl A():1-573. PubMed ID: 16470248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenomics for the treatment of dementia.
    Cacabelos R
    Ann Med; 2002; 34(5):357-79. PubMed ID: 12452480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alzheimer's disease pathogenesis and therapeutic interventions.
    Parihar MS; Hemnani T
    J Clin Neurosci; 2004 Jun; 11(5):456-67. PubMed ID: 15177383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenomic protocols in CNS disorders and dementia.
    Cacabelos R
    Neurodegener Dis; 2010; 7(1-3):167-9. PubMed ID: 20197699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complex disease-associated pharmacogenetics: drug efficacy, drug safety, and confirmation of a pathogenetic hypothesis (Alzheimer's disease).
    Roses AD; Saunders AM; Huang Y; Strum J; Weisgraber KH; Mahley RW
    Pharmacogenomics J; 2007 Feb; 7(1):10-28. PubMed ID: 16770341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapy of Alzheimer disease].
    Kovács T
    Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenetic aspects of therapy with cholinesterase inhibitors: the role of CYP2D6 in Alzheimer's disease pharmacogenetics.
    Cacabelos R; Llovo R; Fraile C; Fernández-Novoa L
    Curr Alzheimer Res; 2007 Sep; 4(4):479-500. PubMed ID: 17908053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic characterization of Alzheimer's disease and genotype-related phenotypic analysis of biological markers in dementia.
    Cacabelos R
    Pharmacogenomics; 2004 Dec; 5(8):1049-105. PubMed ID: 15584876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of paraoxonase 1 genetic variants in Alzheimer's disease neuropathology.
    Leduc V; Théroux L; Dea D; Robitaille Y; Poirier J
    Eur J Neurosci; 2009 Nov; 30(9):1823-30. PubMed ID: 19863653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ApoE genotype accounts for the vast majority of AD risk and AD pathology.
    Raber J; Huang Y; Ashford JW
    Neurobiol Aging; 2004; 25(5):641-50. PubMed ID: 15172743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 68.